NEOPROFEN Side Effects

6920312-7 | Bilirubin Conjugated Increased, Platelet Count Decreased, Product Quality Issue, Red Blood Cell Morphology Abnormal
on Jul 30, 2010 Female patient from UNITED STATES , weighting 2.71 lb, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, platelet count decreased, product quality issue, red blood cell morphology abnormal. Neoprofen dosage: See Image.

6612244-9 |
Patient was taking Neoprofen (View Usage). on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , 28 years of age, . Neoprofen dosage: . During the same period patient was treated with CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ), OPIOID (View Opioid Review and Opioid Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE (View Guaifenesin And Pseudoephedrine Hydrochloride Review and Guaifenesin And Pseudoephedrine Hydrochloride Label ).

6292198-8 | No Therapeutic Response, Oxygen Saturation Decreased, Tracheal Haemorrhage
Adverse event was reported on Jul 30, 2009 by a Female patient taking Neoprofen (View Usage) (Dosage: 3.5 Mg Once Iv) was diagnosed with patent ductus arteriosus and. Location: UNITED STATES , weighting 1.59 lb, After Neoprofen was administered, patient had the following side effects: no therapeutic response, oxygen saturation decreased, tracheal haemorrhage. During the same period patient was treated with CAFFEINE INJ (View Caffeine Inj Review and Caffeine Inj Label ), TPN/FAT EMULSION (View Tpn/fat Emulsion Review and Tpn/fat Emulsion Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ).

6053069-5 |
on Jan 08, 2009 Female patient from UNITED STATES , 20 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: . During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), ETODOLAC (View Etodolac Review and Etodolac Label ), PHENTERMINE (View Phentermine Review and Phentermine Label ).


5759558-2 | Anuria, Aspiration, Blood Creatinine Decreased, Ileal Perforation, Intestinal Perforation, Meconium Increased, Skin Discolouration, Urine Output Decreased, Waist Circumference Increased
on Jun 04, 2008 Male patient from UNITED STATES , weighting 1.43 lb, was diagnosed with patent ductus arteriosus repair and was treated with Neoprofen (View Usage). Patient had the following side effects: anuria, aspiration, blood creatinine decreased, ileal perforation, intestinal perforation, meconium increased, skin discolouration, urine output decreased, waist circumference increased. Neoprofen dosage: 10mg/kg X 1 042; 5mg/kg Q24hrs X 2 Doses 042.

5759557-0 | Intestinal Perforation, Neonatal Hypotension, Peritoneal Fluid Analysis Abnormal
Patient was taking Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: intestinal perforation, neonatal hypotension, peritoneal fluid analysis abnormal on Jun 04, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 1.41 lb, was diagnosed with patent ductus arteriosus and. Neoprofen dosage: 10mg/kg X1 042; 5mg/kg Q24 Hrs X 2 Doses 042.

5759552-1 | Abdominal Abscess, Abdominal Distension, Ileal Perforation, Intestinal Perforation, Skin Discolouration
Adverse event was reported on Jun 04, 2008 by a Female patient taking Neoprofen (View Usage) (Dosage: 10mg/kg X 1 042; 5mg/kg Q24hrs X 2 Doses 042) was diagnosed with patent ductus arteriosus repair and. Location: UNITED STATES , weighting 1.54 lb, Patient experienced the following unwanted or unexpected effects: abdominal abscess, abdominal distension, ileal perforation, intestinal perforation, skin discolouration.

5714123-8 | Intraventricular Haemorrhage
on Apr 22, 2008 Female patient from UNITED STATES , weighting 1.50 lb, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). Patient had the following side effects: intraventricular haemorrhage. Neoprofen dosage: 7 Mg X1, 3.5 Mgx2 Q24h Iv Bolus.

5629017-6 | Completed Suicide
on Jan 31, 2008 Male patient from UNITED STATES , 26 years of age, was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: completed suicide. Neoprofen dosage: Po. During the same period patient was treated with LAMOTRIGINE (Po) (View Lamotrigine Review and Lamotrigine Label ), ESCITALOPRAM (Po) (View Escitalopram Review and Escitalopram Label ), PYRAZOLOPYRIMIDINE (Po) (View Pyrazolopyrimidine Review and Pyrazolopyrimidine Label ), ZOLPIDEM (Po) (View Zolpidem Review and Zolpidem Label ), RAMELTEON (Po) (View Ramelteon Review and Ramelteon Label ), ALPRAZOLAM (Po) (View Alprazolam Review and Alprazolam Label ).

5629016-4 | Agitation, Apnoea, Completed Suicide, Depressed Level Of Consciousness, Dyskinesia
Patient was taking Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, apnoea, completed suicide, depressed level of consciousness, dyskinesia on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 36 years of age, . Neoprofen dosage: Po. During the same period patient was treated with BUPROPION HCL (Po) (View Bupropion Hcl Review and Bupropion Hcl Label ), BETA BLOCKER (Po) (View Beta Blocker Review and Beta Blocker Label ), LAMOTRIGINE (Po) (View Lamotrigine Review and Lamotrigine Label ), CARBON BLACK (View Carbon Black Review and Carbon Black Label ).

5629015-2 | Completed Suicide
Adverse event was reported on Feb 14, 2008 by a Female patient taking Neoprofen (View Usage) (Dosage: Po) . Location: UNITED STATES , 45 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (Po) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), CARISOPRODOL (Po) (View Carisoprodol Review and Carisoprodol Label ), ALPRAZOLAM (Po) (View Alprazolam Review and Alprazolam Label ).

5629014-0 |
on Jan 31, 2008 Male patient from UNITED STATES , 50 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: Po. During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (Po) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ).

5629013-9 |
on Jan 31, 2008 Female patient from UNITED STATES , 26 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: Po. During the same period patient was treated with ACETAMINOPHEN AND OXYCODONE HCL (Po) (View Acetaminophen And Oxycodone Hcl Review and Acetaminophen And Oxycodone Hcl Label ), CYCLOBENZAPRINE HCL (Po) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ).

5629012-7 | Completed Suicide
Patient was taking Neoprofen (View Usage). Patient had the following side effects: completed suicide on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 43 years of age, . Neoprofen dosage: Po. During the same period patient was treated with ACETAMINOPHEN (Po) (View Acetaminophen Review and Acetaminophen Label ), FAMOTIDINE (Po) (View Famotidine Review and Famotidine Label ), DIPHENHYDRAMINE HCL (Po) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

5628887-5 | Completed Suicide
Adverse event was reported on Jan 31, 2008 by a Male patient taking Neoprofen (View Usage) (Dosage: ; Po) . Location: UNITED STATES , 52 years of age, After Neoprofen was administered, patient had the following side effects: completed suicide. During the same period patient was treated with PROPAFENONE HCL (; Po) (View Propafenone Hcl Review and Propafenone Hcl Label ), CARDIAC GLYCOSIDES (; Po) (View Cardiac Glycosides Review and Cardiac Glycosides Label ), CARVEDILOL (; Po) (View Carvedilol Review and Carvedilol Label ), ACETAMINOPHEN W/OPIOID (; Po) (View Acetaminophen W/opioid Review and Acetaminophen W/opioid Label ), TEMAZEPAM (; Po) (View Temazepam Review and Temazepam Label ), OXAZEPAM (; Po) (View Oxazepam Review and Oxazepam Label ), DIURETIC POTASSIUM SPARING (; Po) (View Diuretic-potassium Sparing Review and Diuretic-potassium Sparing Label ), WARFARIN SODIUM (; Po) (View Warfarin Sodium Review and Warfarin Sodium Label ).

5628886-3 |
on Jan 31, 2008 Male patient from UNITED STATES , 51 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: ; Po. During the same period patient was treated with AMITRIPTYLINE HCL (; Po) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), DIHYDROCODONE (; Po) (View Dihydrocodone Review and Dihydrocodone Label ), BENZODIAZEPINE (; Po) (View Benzodiazepine Review and Benzodiazepine Label ), BUTALBITAL (; Po) (View Butalbital Review and Butalbital Label ), ETHANOL (; Po) (View Ethanol Review and Ethanol Label ), CAFFEINE CITRATE (; Po) (View Caffeine Citrate Review and Caffeine Citrate Label ).

5628885-1 | Completed Suicide
on Jan 31, 2008 Male patient from UNITED STATES , 20 years of age, was treated with Neoprofen (View Usage). Patient had the following side effects: completed suicide. Neoprofen dosage: ; Po. During the same period patient was treated with ASPIRIN (; Po) (View Aspirin Review and Aspirin Label ), PSEUDOEPHEDRINE HCL (; Po) (View Pseudoephedrine Hcl Review and Pseudoephedrine Hcl Label ).

5628884-X |
Patient was taking Neoprofen (View Usage). on Feb 14, 2008 from UNITED STATES Additional patient health information: Male patient , 55 years of age, . Neoprofen dosage: ;po. During the same period patient was treated with ACETAMINOPHEN (;po) (View Acetaminophen Review and Acetaminophen Label ).

5628878-4 |
Adverse event was reported on Jan 31, 2008 by a Male patient taking Neoprofen (View Usage) (Dosage: ; Po) . Location: UNITED STATES , 78 years of age, . During the same period patient was treated with FUROSEMIDE (; Po) (View Furosemide Review and Furosemide Label ).

5628877-2 |
on Jan 31, 2008 Female patient from UNITED STATES , 52 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: ; Po. During the same period patient was treated with FENTANYL (; Po) (View Fentanyl Review and Fentanyl Label ), DOXEPIN HCL (; Po) (View Doxepin Hcl Review and Doxepin Hcl Label ), BUPROPION HCL (; Po) (View Bupropion Hcl Review and Bupropion Hcl Label ), FLUOXETINE (; Po) (View Fluoxetine Review and Fluoxetine Label ), AMOXICILLIN (; Po) (View Amoxicillin Review and Amoxicillin Label ), PREGABALIN (; Po) (View Pregabalin Review and Pregabalin Label ), METHOCARBAMOL (; Po) (View Methocarbamol Review and Methocarbamol Label ), ATORVASTATIN CALCIUM (; Po) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5628876-0 | Completed Suicide
on Jan 31, 2008 Male patient from UNITED STATES , 27 years of age, was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: completed suicide. Neoprofen dosage: ; Po. During the same period patient was treated with HYDROCODONE BITARTRATE (; Po) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ).

5628875-9 | Completed Suicide
Patient was taking Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 41 years of age, . Neoprofen dosage: ; Po. During the same period patient was treated with ETHANOL (; Po) (View Ethanol Review and Ethanol Label ).

5628867-X | Completed Suicide
Adverse event was reported on Jan 31, 2008 by a Female patient taking Neoprofen (View Usage) (Dosage: ; Po) . Location: UNITED STATES , 48 years of age, Patient had the following side effects: completed suicide.

5628866-8 | Completed Suicide
on Jan 31, 2008 Female patient from UNITED STATES , 39 years of age, was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: completed suicide. Neoprofen dosage: ; Po. During the same period patient was treated with QUETIAPINE FUMARATE (; Po) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), ANGIOTENSIN RECEPTOR BLOCKER (; Po) (View Angiotensin Receptor Blocker Review and Angiotensin Receptor Blocker Label ), BUTALBITAL ACETAMINOPHEN AND CAFFEINE (; Po) (View Butalbital Acetaminophen And Caffeine Review and Butalbital Acetaminophen And Caffeine Label ), ASPIRIN (; Po) (View Aspirin Review and Aspirin Label ), ESCITALOPRAM OXALATE (; Po) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), CAFFEINE CITRATE (; Po) (View Caffeine Citrate Review and Caffeine Citrate Label ), NAPROXEN (; Po) (View Naproxen Review and Naproxen Label ).

5628865-6 |
on Jan 31, 2008 Male patient from UNITED STATES , 26 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: ; Po. During the same period patient was treated with METHADONE HCL (; Po) (View Methadone Hcl Review and Methadone Hcl Label ), ALPRAZOLAM (; Po) (View Alprazolam Review and Alprazolam Label ).

5628864-4 | Completed Suicide
Patient was taking Neoprofen (View Usage). Patient had the following side effects: completed suicide on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 40 years of age, was diagnosed with completed suicide and. Neoprofen dosage: ; Po. During the same period patient was treated with QUETIAPINE FUMARATE (; Po) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), DIAZEPAM (; Po) (View Diazepam Review and Diazepam Label ), BENZODIAZEPINE DERIVATIVES (; Po) (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), LAMOTRIGINE (; Po) (View Lamotrigine Review and Lamotrigine Label ), ZOLPIDEM (; Po) (View Zolpidem Review and Zolpidem Label ), LORATADINE (; Po) (View Loratadine Review and Loratadine Label ), TIAGABINE HCL (; Po) (View Tiagabine Hcl Review and Tiagabine Hcl Label ).

5628863-2 |
Adverse event was reported on Jan 31, 2008 by a Female patient taking Neoprofen (View Usage) (Dosage: ) . Location: UNITED STATES , 50 years of age, . During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), ACETAMINOPHEN AND OXYCODONE HCL (View Acetaminophen And Oxycodone Hcl Review and Acetaminophen And Oxycodone Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5628856-5 | Completed Suicide
on Jan 31, 2008 Male patient from UNITED STATES , 25 years of age, was treated with Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Neoprofen dosage: ; Po. During the same period patient was treated with CAFFEINE CITRATE (; Po) (View Caffeine Citrate Review and Caffeine Citrate Label ), DIPHENHYDRAMINE HCL (; Po) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

5628852-8 |
on Jan 31, 2008 Male patient from UNITED STATES , 43 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: Po. During the same period patient was treated with OXYCODONE HCL (Po) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), TIZANIDINE HCL (Po) (View Tizanidine Hcl Review and Tizanidine Hcl Label ), ACETAMINOPHEN (Po) (View Acetaminophen Review and Acetaminophen Label ), CARISOPRODOL (Po) (View Carisoprodol Review and Carisoprodol Label ), PROMETHAZINE (Po) (View Promethazine Review and Promethazine Label ).

5628851-6 |
Patient was taking Neoprofen (View Usage). on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 48 years of age, . Neoprofen dosage: . During the same period patient was treated with HEROIN (View Heroin Review and Heroin Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

5628845-0 | Completed Suicide
Adverse event was reported on Jan 31, 2008 by a Male patient taking Neoprofen (View Usage) (Dosage: Po) . Location: UNITED STATES , 25 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide. During the same period patient was treated with ETHANOL (Po) (View Ethanol Review and Ethanol Label ).

5628811-5 |
on Jan 31, 2008 Male patient from UNITED STATES , 19 years of age, was treated with Neoprofen (View Usage). . Neoprofen dosage: Po. During the same period patient was treated with ASPIRIN (Po) (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (Po) (View Acetaminophen Review and Acetaminophen Label ), ETHANOL (Po) (View Ethanol Review and Ethanol Label ).

5628809-7 | Completed Suicide
on Jan 31, 2008 Female patient from UNITED STATES , 21 years of age, was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: completed suicide. Neoprofen dosage: Po. During the same period patient was treated with ACETAMINOPHEN (Po) (View Acetaminophen Review and Acetaminophen Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (Po) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ), CYCLOBENZAPRINE HCL (Po) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ).

5628807-3 | Completed Suicide
Patient was taking Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Jan 31, 2008 from UNITED STATES Additional patient health information: Female patient , 30 years of age, . Neoprofen dosage: Po. During the same period patient was treated with AMANTADINE HCL (Po) (View Amantadine Hcl Review and Amantadine Hcl Label ), ZIPRASIDONE HCL (Po) (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ).

5628806-1 | Completed Suicide
Adverse event was reported on Jan 31, 2008 by a Female patient taking Neoprofen (View Usage) (Dosage: Po) . Location: UNITED STATES , 63 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with ACETAMINOPHEN (Po) (View Acetaminophen Review and Acetaminophen Label ).

5628795-X | Completed Suicide
on Jan 31, 2008 Female patient from UNITED STATES , 35 years of age, was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: completed suicide. Neoprofen dosage: Po. During the same period patient was treated with ASPIRIN (Po) (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (Po) (View Acetaminophen Review and Acetaminophen Label ).

5628792-4 | Completed Suicide
on Jan 31, 2008 Male patient from UNITED STATES , 62 years of age, was treated with Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Neoprofen dosage: Po. During the same period patient was treated with ASPIRIN (Po) (View Aspirin Review and Aspirin Label ), PSEUDOEPHEDRINE HCL (Po) (View Pseudoephedrine Hcl Review and Pseudoephedrine Hcl Label ), AMOXICILLIN (Po) (View Amoxicillin Review and Amoxicillin Label ), DEXTROMETHORPHAN HYDROBROMIDE (Po) (View Dextromethorphan Hydrobromide Review and Dextromethorphan Hydrobromide Label ).

5628790-0 |
Patient was taking Neoprofen (View Usage). on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Neoprofen dosage: Po. During the same period patient was treated with OXYCODONE HCL (Po) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ANTIHISTAMINES (Po) (View Antihistamines Review and Antihistamines Label ), BUPROPION HCL (Po) (View Bupropion Hcl Review and Bupropion Hcl Label ), SERTRALINE (Po) (View Sertraline Review and Sertraline Label ).

5628788-2 | Completed Suicide
Adverse event was reported on Jan 31, 2008 by a Female patient taking Neoprofen (View Usage) (Dosage: Po) . Location: UNITED STATES , 50 years of age, After Neoprofen was administered, patient had the following side effects: completed suicide. During the same period patient was treated with FUROSEMIDE (Po) (View Furosemide Review and Furosemide Label ), CARDIAC GLYCOSIDES (Po) (View Cardiac Glycosides Review and Cardiac Glycosides Label ).

5593263-0 | Necrotising Colitis
on Jan 15, 2008 Male patient from UNITED STATES , weighting 4.41 lb, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: necrotising colitis. Neoprofen dosage: 7 Mg Once Po.

5530281-2 | Intestinal Perforation, Sepsis
on Nov 27, 2007 Female patient from UNITED STATES , weighting 1.74 lb, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). Patient had the following side effects: intestinal perforation, sepsis (What is sepsis?). Neoprofen dosage: 8.57 Mg Daily Iv; 3.8 Mg Daily Iv. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ). Patient was hospitalized.

5507659-6 | No Therapeutic Response, Refusal Of Treatment By Relative, Renal Failure
Patient was taking Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: no therapeutic response, refusal of treatment by relative, renal failure on Nov 05, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 3.79 lb, was diagnosed with patent ductus arteriosus and. Neoprofen dosage: 8 Mg Once -loading Dose- Iv Bolus 4mg Q24h X 2 Iv Bolus. During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), TPN/FAT EMULSION (View Tpn/fat Emulsion Review and Tpn/fat Emulsion Label ), LASIX (View Lasix Review and Lasix Label ), MORPHINE (View Morphine Review and Morphine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

5485612-9 | Erythema, Fungal Infection, Intestinal Perforation, Neutropenia
Adverse event was reported on Oct 11, 2007 by a Female patient taking Neoprofen (View Usage) (Dosage: 10mg/kg -1st Dose- 1 Dose Iv) was diagnosed with patent ductus arteriosus and. Location: UNITED STATES , weighting 1.26 lb, Patient experienced the following unwanted or unexpected effects: erythema, fungal infection (What is fungal infection?), intestinal perforation, neutropenia.

5416531-1 | Renal Failure Neonatal
on Aug 15, 2007 Male patient from UNITED STATES , weighting 1.32 lb, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). Patient had the following side effects: renal failure neonatal. Neoprofen dosage: 6.2 Mg Q24h Iv.

5404762-6 | Dehydration, Procedural Vomiting, Renal Failure Acute
on Jul 17, 2007 Male patient from UNITED KINGDOM , child 7 years of age, was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: dehydration, procedural vomiting, renal failure acute. Neoprofen dosage: 10 Mg/kg;tid;. During the same period patient was treated with INDOMETHACIN (25 Mg;bid;) (View Indomethacin Review and Indomethacin Label ), DICLOFENAC SODIUM (;rtl) (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

5386297-2 | Hyperbilirubinaemia
Patient was taking Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia on Jul 10, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 2.22 lb, was diagnosed with patent ductus arteriosus and. Neoprofen dosage: See Image. During the same period patient was treated with CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), IV FAT EMULSIONK (View Iv Fat Emulsionk Review and Iv Fat Emulsionk Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TPN (View Tpn Review and Tpn Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ).

5302935-4 | Abdominal Distension, Intestinal Perforation, Necrotising Enterocolitis Neonatal
Adverse event was reported on Apr 02, 2007 by a Male patient taking Neoprofen (View Usage) (Dosage: See Image) was diagnosed with patent ductus arteriosus and. Location: UNITED STATES , weighting 1.72 lb, Patient had the following side effects: abdominal distension, intestinal perforation, necrotising enterocolitis neonatal.

5302923-8 | Abdominal Distension, Intestinal Perforation, Necrotising Enterocolitis Neonatal
on Apr 02, 2007 Male patient from UNITED STATES , weighting 1.72 lb, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). After Neoprofen was administered, patient had the following side effects: abdominal distension, intestinal perforation, necrotising enterocolitis neonatal. Neoprofen dosage: See Image.

5169028-0 | Gastrointestinal Perforation
on Nov 16, 2006 Male patient from UNITED STATES , child .0 years of age, was diagnosed with patent ductus arteriosus and was treated with Neoprofen (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal perforation. Neoprofen dosage: Iv. During the same period patient was treated with DOPAMINE (View Dopamine Review and Dopamine Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LUNG SURFACTANTS (View Lung Surfactants Review and Lung Surfactants Label ).

5169027-9 | Gastrointestinal Perforation, Neonatal Disorder
Patient was taking Neoprofen (View Usage). Patient had the following side effects: gastrointestinal perforation, neonatal disorder on Nov 16, 2006 from UNITED STATES Additional patient health information: Male patient , child .0 years of age, was diagnosed with patent ductus arteriosus and. Neoprofen dosage: See Image, Iv. During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), VERSED (View Versed Review and Versed Label ), SURFACTANT (View Surfactant Review and Surfactant Label ).